Doblan, AhmetAk, S.Kaplama, M.E.Müderris, Togay2022-02-152022-02-1520210196-0709https://doi.org/10.1016/j.amjoto.2021.103145https://hdl.handle.net/20.500.14034/194[No abstract available]eninfo:eu-repo/semantics/openAccessantihypertensive agentantimalarial agentantivirus agentcorticosteroidhydroxychloroquineimmunosuppressive agentanosmiaArticleclinical protocolcoronavirus disease 2019corticosteroid therapydisease exacerbationdrug efficacydrug safetyhumanlung diseasepandemicperception deafnesspractice guidelineSevere acute respiratory syndrome coronavirus 2sudden deafnessTurkey (republic)World Health OrganizationLetter10.1016/j.amjoto.2021.1031454252-s2.0-8510894025034215465Q1